As the evolution of oncology care continues, a critical Oncology Navigation Standard of Professional Practice is Standard 3: Knowledge. It supports that oncology navigators have and continue to seek knowledge that reflects current navigation practice. This is based on the foundation that professional navigators have oncology-related educational and employment experience. The expanding treatment landscape from chemical agents (drugs) to generic medication and now biologic agents to biosimilars creates a fertile ground for basic navigator education as well as enhanced communication by healthcare providers to shape patients’ perceptions and alleviate their concerns on changing therapy.
It is important that all navigators fully understand biosimilars so that they have an increased confidence in addressing the “nocebo” effect and play a crucial role in their successful integration into cancer care. Oncology navigators can help patients understand the benefits and potential of biosimilars, navigate the complexities of the healthcare system, and ensure patients receive the most appropriate and cost-effective treatment. Financial navigators play a huge role in working with patients about payment for this newer therapy.
They can educate patients and the community about the safety and efficacy of biosimilars, augment understanding on the different biosimilar options available for specific cancer types and treatment plans, and address concerns about the safety or effectiveness of biosimilars by providing evidence-based information and reassurance that biosimilars are safe and effective. The foundational outcome is helping patients make informed decisions about their cancer treatment, which can lead to improved outcomes, better quality of life, reduced healthcare costs, and increased access to treatment.
All oncology navigators can help implement strategies to optimize the use of biosimilars, ensuring that patients receive cost-effective treatment without compromising quality of care.
Keep up to date with the latest news from us via social networks:
To sign up for our print publication or e-newsletter, please enter your contact information below.
